Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Víctor SapenaMarco EneaFerràn TorresCiro CelsaJose RíosGiacomo Emanuele Maria RizzoPierre NahonZoe MariñoRyosuke TateishiTatsuya MinamiAngelo SangiovanniXavier FornsHidenori ToyodaStefano BrillantiFabio ContiElisabetta DegasperiMing-Lung YuPei-Chien TsaiKévin JeanMohamed El KassasHend Ibrahim ShoushaAshraf OmarClaudio ZavagliaHiroko NagataMina NakagawaYasuhiro AsahinaAmit G SingalCaitlin C MurphyMohamed Ahmed Samy KohlaChiara MasettiJean-François DufourNicolás MerchanteLuisa CavallettoLiliana Lc ChemelloStanislas PolJavier CrespoJose Luis CallejaRosanna VillaniGaetano ServiddioAlberto ZanettoSarah ShalabyFrancesco Paolo RussoRob BielenFranco TrevisaniCalogero CammàJordi BruixGiuseppe CabibboMaria ReigPublished in: Gut (2021)
Effects of DAA exposure on HCC recurrence risk remain inconclusive. Active clinical and radiological follow-up of patients with HCC after HCV eradication with DAA is justified.